S&P・Nasdaq 本質的価値 お問い合わせ

DNAPrint Genomics, Inc. DNAG OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

DNAPrint Genomics, Inc. (DNAG) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Sarasota, アメリカ. 現CEOは Jatin Patel.

DNAG を有する IPO日 2001-02-22, 24 名の正社員, に上場 Other OTC, 時価総額 $6.45K.

DNAPrint Genomics, Inc. について

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.

📍 1621 West University Parkway, Sarasota
会社詳細
セクターヘルスケア
業種バイオテクノロジー
アメリカ
取引所Other OTC
通貨USD
IPO日2001-02-22
CEOJatin Patel
従業員数24
取引情報
現在価格$0.00
時価総額$6.45K
52週レンジ0.000001-0.00002
ベータ1.53
ETFいいえ
ADRいいえ
CUSIP23324Q202
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る